Ayurveda tech startup NirogStreet snaps up $12M in Collection B funding
NirogStreet, an Ayurveda know-how platform in India, has scored $12 million in a Collection B funding spherical led by Jungle Ventures.
It offers a group for Ayurveda docs and an e-commerce platform that streamlines the availability chain of Ayurvedic providers and drugs. NirogStreet has onboarded round 50,000 medical practitioners and about 50 Ayurveda manufacturers.
The startup will use the proceeds from its newest investing spherical to bolster its provide chain, know-how, and providers.
Males’s well being startup Bonatra obtains pre-seed funding
Bonatra, a males’s health-focused startup from India, has raised INR 55 million ($670,000) in a pre-seed funding spherical led by ITI Progress Alternatives Fund with the participation of marquee angel traders, Jitendra Jagadev, founding father of Nestaway, and Blackbuck founder Rajesh Yabaji.
The corporate runs a know-how platform that provides personalised well being programmes concentrating on power circumstances of males.
In an announcement, Bonatra stated that its recent funds will likely be used to increase its choices, construct its workforce, and develop its shopper base.
Edenlux introduces AI report back to its cell eye well being app
South Korean medical gadget maker Edenlux is now offering AI-generated eye well being administration reviews by way of its flagship cell app Otus Plus.
The app permits customers to check their eye well being with a paired goggle gadget, do gamified eye workout routines, and obtain an eye fixed well being report.
Its eye well being reviews now comprise AI-generated eye well being scores, evaluation of eye focus response pace, and outcomes of eye train video games primarily based on customers’ knowledge.
Sooner or later, Edenlux plans so as to add an enchancment indicator to its reviews, in addition to provide a service that enables customers to decide on their very own customised lenses for eye workout routines and use amassed knowledge to supply an eye fixed well being rating report.
Cha Vaccine ties up with MOGAM for AI drug discovery
The MOGAM Institute for Biomedical Analysis has signed a memorandum of understanding with the Cha Vaccine Institute for AI drug discovery.
They’ll cooperate to develop new medication and enhance drug substances utilizing MOGAM’s AI algorithms, which will likely be examined utilizing medical knowledge from Cha Vaccine. Later, they may conduct joint research and apply for co-patents.